Ana Tari Ashizawa
Affiliations: | Neuroscience | University of Florida, Gainesville, Gainesville, FL, United States |
Area:
Aging & Memory Loss,Neurodegeneration,Lipid Nanoparticles, Liposome Formulations, Small Molecule Delivery,Oligonucleotide DeliveryGoogle:
"Ana Ashizawa"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gagliardi M, Ashizawa AT. (2021) The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery. Biomedicines. 9 |
Ohanian M, Lin TL, Craig M, et al. (2020) A phase II study of BP1001 (liposomal Grb2 antisense oligonucleotide) in patients with hematologic malignancies. Journal of Clinical Oncology. 38 |
Ashizawa AT, Holt J, Faust K, et al. (2018) Intravenously Administered Novel Liposomes, DCL64, Deliver Oligonucleotides to Cerebellar Purkinje Cells. Cerebellum (London, England) |
Ashizawa AT, Ohanian M, Cortes JE. (2016) BP1001, a Novel Therapeutic for Chronic Myelogenous Leukemia Blood. 128: 4239-4239 |
Ashizawa AT, Cortes J. (2015) Liposomal delivery of nucleic acid-based anticancer therapeutics: BP-100-1.01. Expert Opinion On Drug Delivery. 12: 1107-20 |
Holt J, Martuscello R, Deleyrolle L, et al. (2015) Ddel-03Intravenous Nanoparticle Delivery To Glioblastoma Neuro-Oncology. 17 |
Ashizawa AT, Steindler D. (2014) ET-61 * NOVEL LIPID NANOPARTICLES FOR THE DELIVERY OF NUCLEIC ACIDS TO GLIOBLASTOMA Neuro-Oncology. 16: v92-v92 |
Lee S, Ashizawa AT, Kim KS, et al. (2013) Liposomes to target peripheral neurons and Schwann cells. Plos One. 8: e78724 |